Lisl Dunlop wins commendations from peers across North America who consider her a go-to figure in the market for antitrust-related litigation and transactional matters.
Lisl Dunlop has more than 25 years of experience in antitrust and competition issues, including counselling, litigation and transactions. Lisl guides clients through the antitrust-related aspects of mergers and acquisitions, joint ventures and other combinations, and sales and distribution matters. She also represents clients in antitrust agency investigations and has represented major corporations in complex antitrust litigations. Lisl has significant experience advising leading US and multinational companies in a broad range of industries, including the media, technology and healthcare sectors. For her healthcare clients, Lisl provides antitrust and strategic advice in evaluating value-based payment initiatives, the establishment and operation of ACOs and independent physician networks, financial and clinical integration issues, and other transactions and collaborations. Lisl began her career in Australia, and in addition to the US has also practised in the UK. Her wide-ranging international experience includes appearing before US federal and state antitrust enforcement agencies, the European Commission, and UK and Australian antitrust authorities. Additionally, she has coordinated the multijurisdictional defence of transactions throughout the world. Lisl’s experience in competition matters in a broad range of jurisdictions brings added value to clients that conduct business internationally and interact with different legal systems and regulators.
Lisl’s recent publications on antitrust include the following: Co-author, “New York Attorney General's Cartel Bust Is Just the Beginning” (Crain’s New York Business, June 2018); Co-author, “Net Neutrality: From Rules to Enforcement” (Electronic Retailing Association, December 2017); “Certificates of Public Advantage: Bypassing the FTC in Healthcare Mergers” (Competition, Winter 2017–2018); “Why Amazon's Whole Foods Buy Is Likely to Be Cleared” (Law360, June 2017).
Lisl is a member of the New York State Bar Association antitrust section executive committee and was chair in 2016. She is vice chair of the American Bar Association section of antitrust – mergers & acquisitions committee; a member of the American Health Lawyers Association antitrust practice group and on the 2019 Law360 competition editorial advisory board.
Lisl received her LLM from Cornell University Law School in 1997 and her LLB and BSc from the University of Sydney in 1991.